Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.

Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV, Ancliff P, Morgan M, Masurekar A, Goulden N, Green N, Révész T, Darbyshire P, Love S, Saha V.

Lancet. 2010 Dec 11;376(9757):2009-17. doi: 10.1016/S0140-6736(10)62002-8. Epub 2010 Dec 3.

2.

A systematic overview of chemotherapy effects in acute myeloid leukaemia.

Kimby E, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):231-52. Review.

PMID:
11441935
3.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
4.

Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.

J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. Review.

PMID:
11902303
5.

The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.

Li X, Xu S, Tan Y, Chen J.

Cochrane Database Syst Rev. 2015 Jun 3;(6):CD010432. doi: 10.1002/14651858.CD010432.pub2. Review.

PMID:
26037486
6.

Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.

Matsuzaki A, Ishii E, Nagatoshi Y, Eguchi H, Koga H, Yanai F, Inada H, Nibu K, Tamai Y, Akiyoshi K, Nakayama H, Hara T, Take H, Miyazaki S, Okamura J.

Int J Hematol. 2001 Apr;73(3):369-77. Review.

PMID:
11345205
7.

[Experience with fludarabine treatment and review of the literature].

Telek B, Rejtó L, Kiss A, Batár P, Reményi G, Rák K, Udvardy M.

Orv Hetil. 2002 Jun 16;143(24):1459-65. Review. Hungarian.

PMID:
12138643
8.

Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5,659 children.

Eden T, Pieters R, Richards S; Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)..

Br J Haematol. 2010 Jun;149(5):722-33. doi: 10.1111/j.1365-2141.2010.08148.x. Epub 2010 Mar 16. Review.

PMID:
20331462
9.

Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.

Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)..

Br J Haematol. 2009 May;145(3):376-88. doi: 10.1111/j.1365-2141.2009.07624.x. Epub 2009 Feb 22. Review.

10.

Treatment of pediatric acute lymphoblastic leukemia.

Cooper SL, Brown PA.

Pediatr Clin North Am. 2015 Feb;62(1):61-73. doi: 10.1016/j.pcl.2014.09.006. Epub 2014 Oct 18. Review.

11.

The Effectiveness of Incorporating a Play-based Intervention to Improve Functional Mobility for a Child with Relapsed Acute Lymphoblastic Leukaemia: A Case Report.

Vercher P, Hung YJ, Ko M.

Physiother Res Int. 2016 Dec;21(4):264-270. doi: 10.1002/pri.1663. Epub 2016 Feb 19. Review.

PMID:
26892073
12.

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

Gaynon PS, Sun W.

Br J Haematol. 2016 Jun;173(6):950-7. doi: 10.1111/bjh.14143. Epub 2016 May 25. Review.

PMID:
27221005
13.

Treatment-related toxicities in children with acute lymphoblastic leukaemia predisposition syndromes.

Schmiegelow K.

Eur J Med Genet. 2016 Dec;59(12):654-660. doi: 10.1016/j.ejmg.2016.02.006. Epub 2016 Feb 11. Review.

PMID:
26876989
14.

Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.

Tasian SK, Hunger SP.

Br J Haematol. 2017 Mar;176(6):867-882. doi: 10.1111/bjh.14474. Epub 2016 Dec 16. Review.

PMID:
27984637
15.

Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities.

López Villar E, Wu D, Cho WC, Madero L, Wang X.

J Cell Mol Med. 2014 Jul;18(7):1239-46. doi: 10.1111/jcmm.12319. Epub 2014 Jun 9. Review.

Supplemental Content

Support Center